Sabine is a physician and Director Research & Development at Profil. She has been working in diabetes since 1989, starting with Professor Michael Berger’s group at the Clinic of Metabolic Diseases and Nutrition, Heinrich-Heine University hospital, Duesseldorf, where she worked for several years. Afterwards she was with Novo Nordisk for 9 years, being responsible for quite a number of clinical trials in Germany, Austria and Switzerland, especially short- and long-acting insulin analogue, and inhaled insulin trials. Sabine joined her former University colleagues Prof. Lutz Heinemann and Dr Tim Heise at Profil in 2003. She has been Principal Investigator for several clinical phase I PK/PD and glucose clamp trials with new antidiabetic compounds.

1983 - 1989	Studies of Medicine, Heinrich-Heine University Düsseldorf
1989	Preliminary license to practice medicine
1991	License to practice medicine
1993	Doctoral degree (Dr. med.), Heinrich-Heine University Düsseldorf
08 - 09/2000	80 hours course incl. exam in Clinical Diabetology of the German Diabetes Association (DDG)
1990 - 12/93	Physician: Internal Medicine, Clinic for Metabolic Diseases and Nutrition, Heinrich-Heine University, Düsseldorf, Germany
1994 - 2002	Medical Adviser Diabetes, Novo Nordisk Pharma GmbH, Mainz, Germany
2003 - 04/2005	Director Marketing & Business Development, Profil
05/2005 - 09/2005	Scientist Clinical Pharmacology, Schwarz Biosciences GmbH, Monheim, Germany
10/2005 - 07/2011	Director Clinical Science, Profil
08/2011 -	Director Research & Development, Profil